Bipolar Disorder Information
More articles below:
Study Shows Some Anti-Seizure Meds Raise Suicide Risk
Survey May Help Docs Diagnose Mood Disorders
Antipsychotics Still Widely Used in U.S. Nursing Homes
Lithium Beats Valproate for Long-Term Bipolar Therapy
Antidepressants May Change Your Personality
Bipolar Disorder May Be Tied to Body Clock
Abilify Approved for Children With Bipolar Disorder
FRIDAY, Feb. 29 (HealthDay News) -- The U.S. Food and Drug Administration has approved Abilify (aripiprazole) to treat manic and mixed episodes in children aged 10 to 17 with bipolar 1 disorder, makers Otsuka Pharmaceutical Co. and Bristol-Myers Squibb Inc. said Friday.
The drug has been approved for this and other uses in adults for several years.
The new approval was based on results from a four-week study involving children in this age group. The trial demonstrated the drug's effectiveness compared to a placebo, the drug companies said in a statement.
Abilify was first approved in November 2002, and nearly 15 million prescriptions had been written through December 2007, the statement said.
More information
The FDA has more about this drug.
DON'T HAVE Rx COVERAGE?Click Here to print out your FREE OPTIMIZERx Card and instantly begin savings on your next prescriptions!
